Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT
Matsuda Masaru sold 3,674 Arcutis Biotherapeutics, Inc. shares (Form 4)
Traded Sep 16, 2026 · Filed Sep 18, 2026
On Sep 16, 2026, Matsuda Masaru (See Remarks) sold 3,674 Arcutis Biotherapeutics, Inc. shares at US$25.00 for US$91,850 under a trading plan, leaving 112,508 shares. Filed Sep 18, 2026 (Form 4).
- Sold
- 3,674 shares
- Price
- US$25.00
- Value
- US$91,850
- Holding after
- 112,508 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Common Stock | Sale | 3,674 | US$25.00 | 112,508 | Direct |
Source
Related
- Arcutis Biotherapeutics, Inc.
- Matsuda Masaru
- Arcutis Biotherapeutics, Inc. shareholders
- Form 4 · Matsuda Masaru · Sep 10, 2026
- Form 4 · Matsuda Masaru · Aug 5, 2026
- Form 4 · Matsuda Masaru · May 6, 2026
- Form 4 · Welgus Howard G. · Oct 19, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 5, 2026
- Form 4 · Welgus Howard G. · Sep 17, 2026
- Form 4 · Curran Terrie · Aug 28, 2026
- Form 4 · Curran Terrie · Aug 24, 2026